IKNA: Gunggung dhuwit awis saben saham Ikena Oncology

Lambang korporat lan logo Ikena Oncology Inc. (IKNA)

The oncology sector is traditionally considered a defensive asset due to stable demand for medical services. The cash per share trend reflects the current state of liquidity, where the parameter value equals 23.80. The prospects for Ikena Oncology, Inc. (IKNA) rely on the development of targeted drugs for rare mutations and the use of production outsourcing via US CMOs to minimize infrastructure risks.

IKNA Ikena Oncology: Dana dhuwit saben saham ing interval 04.07.2022 - 09.08.2025

Rincian analitis perusahaan Ikena Oncology, Inc.

- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
Analisis komprehensif perusahaan:Ikena Oncology Inc.
Produk mawa merek Ikena Oncology

This metric reflects the volume of liquid assets per common share, determining the internal protection of capital. For Ikena Oncology, Inc. (IKNA), this reserve is critical for financing the development of the IK-930 inhibitor and solid tumor therapies. By analyzing the cash per share forecast, an investor assesses the company's autonomy from external loans. Excess liquidity guarantees survival during clinical trials; however, an excessive cushion may signal inefficient capital management.

Analisis perusahaan pesaing

Dana dhuwit saben siji saham ONC (BeiGene Corp)|Dhuwit awis saben siji saham HALO (Halozyme Therapeutics, Inc.)|Dhuwit awis saben saham Revolution Medicines, Inc. (RVMD)|Dhuwit awis saben saham AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cekelan dhuwit saben saham|URGN - Dana dhuwit saben saham|Bicara Bio - Dhuwit awis diétung saben siji saham|PSNL: Dhuwit awis saben saham|Dana dhuwit saben siji saham ERAS|Dhuwit awis saben siji saham DCTH|Cekelan dhuwit saben saham Y-mAbs Therapeutics Inc YMAB|Dhuwit awis saben saham AURA|CADL (Candel Therapeutics, Inc.) - Gunggung dhuwit awis saben saham|Dana dhuwit saben saham Accuray Inc ARAY|Dana dhuwit diétung saben saham SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Citius Oncology|HURA: Dhuwit awis saben saham|Dhuwit awis saben lembar saham TARA (Protara)|FATE (fatetherapeutics.com) - Dhuwit awis saben saham|Cekelan dhuwit saben saham Aadi Bioscience WHWK|Dhuwit awis saben saham TCRX|CSBR - Cekelan dhuwit saben saham|XBiotech - Dhuwit awis saben siji saham|CEL-SCI Corporation (CVM) - Cekelan dhuwit saben saham|OSTX - Dana dhuwit saben saham|Cekelan dhuwit saben saham Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Dhuwit awis saben siji saham|ANL (Adlai Nortye Ltd) - Dana dhuwit saben saham|Dhuwit awis saben siji saham VERU|Tempest Therapeutics (TPST) - Dana dhuwit diétung saben saham|Dhuwit awis saben saham XLO|Dhuwit awis saben siji saham Renovaro RENB|Dhuwit awis saben saham MURA (Mural Oncology PLC)|KAPA - Dhuwit awis saben siji saham|OnKure Therapeutics - Dhuwit awis saben saham|w2.cytomed.sg - Dhuwit awis diétung saben siji saham|Curis Corp (CRIS) - Dana dhuwit saben saham|Cekelan dhuwit saben saham Apollomics Corp (APLM)|Dana dhuwit saben saham Tharimmune|Dhuwit awis saben saham advanbiomed.com|Dana dhuwit saben saham Genprex, Inc (GNPX)|Dana dhuwit diétung saben saham Calidi Biotherapeutics, Inc.|Dhuwit awis saben saham SBFM (Sunshine Biopharma Inc.)|XBIO - Dhuwit awis saben siji saham|SLRX: Dhuwit awis saben siji saham|Gunggung dhuwit awis saben saham PPBT (Purple Biotech Ltd.)|AONC: Dhuwit awis saben saham|Cekelan dhuwit saben saham BeOne Medicines (BGNE)|Dana dhuwit saben saham Checkpoint Therapeutics, Inc.|Dhuwit awis saben siji saham Elevation Oncology (ELEV)|Dana dhuwit saben saham iCAD Corp (ICAD)|NTBL (Notable Labs) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham VIRX (Viracta Therapeutics)|Dana dhuwit diétung saben saham MorphoSys AG (MOR)|NAYA Biosciences Corp - Dhuwit awis saben saham|Cekelan dhuwit saben saham ascentage.com